Crinetics Pharmaceuticals (CRNX) shares are up in Monday after-hours after the company announced it will be acquired by Vertex Pharmaceuticals (VRTX). While no deal value or terms are provided in the article, the announced acquisition is a positive catalyst for CRNX equity holders.
Crinetics Pharmaceuticals (CRNX) shares are up in Monday after-hours after the company announced it will be acquired by Vertex Pharmaceuticals (VRTX). While no deal value or terms are provided in the article, the announced acquisition is a positive catalyst for CRNX equity holders.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
